PT2393830E - Péptidos de gramíneas para vacina - Google Patents

Péptidos de gramíneas para vacina Download PDF

Info

Publication number
PT2393830E
PT2393830E PT107043994T PT10704399T PT2393830E PT 2393830 E PT2393830 E PT 2393830E PT 107043994 T PT107043994 T PT 107043994T PT 10704399 T PT10704399 T PT 10704399T PT 2393830 E PT2393830 E PT 2393830E
Authority
PT
Portugal
Prior art keywords
vaccine
grass
peptides
grass peptides
Prior art date
Application number
PT107043994T
Other languages
English (en)
Portuguese (pt)
Inventor
Mark Larche
Paul Laidler
Rod Hafner
Guy Layton
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0901928A external-priority patent/GB0901928D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Priority claimed from GB0917871A external-priority patent/GB0917871D0/en
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of PT2393830E publication Critical patent/PT2393830E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
PT107043994T 2009-02-05 2010-02-05 Péptidos de gramíneas para vacina PT2393830E (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0901928A GB0901928D0 (en) 2009-02-05 2009-02-05 Peptides for vaccine
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production
GB0917871A GB0917871D0 (en) 2009-10-12 2009-10-12 Peptides for vaccine

Publications (1)

Publication Number Publication Date
PT2393830E true PT2393830E (pt) 2015-04-23

Family

ID=42082585

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107043994T PT2393830E (pt) 2009-02-05 2010-02-05 Péptidos de gramíneas para vacina

Country Status (23)

Country Link
US (2) US8753644B2 (cg-RX-API-DMAC7.html)
EP (2) EP2393830B8 (cg-RX-API-DMAC7.html)
JP (2) JP5746053B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110111307A (cg-RX-API-DMAC7.html)
CN (2) CN102307893B (cg-RX-API-DMAC7.html)
AU (1) AU2010212193B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1008802A2 (cg-RX-API-DMAC7.html)
CA (1) CA2751500A1 (cg-RX-API-DMAC7.html)
DK (1) DK2393830T3 (cg-RX-API-DMAC7.html)
EA (1) EA020792B1 (cg-RX-API-DMAC7.html)
ES (1) ES2532759T3 (cg-RX-API-DMAC7.html)
GB (1) GB2469894B (cg-RX-API-DMAC7.html)
HK (1) HK1212358A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20150317T1 (cg-RX-API-DMAC7.html)
IL (1) IL214257A (cg-RX-API-DMAC7.html)
MX (1) MX2011008179A (cg-RX-API-DMAC7.html)
NZ (1) NZ594268A (cg-RX-API-DMAC7.html)
PL (1) PL2393830T3 (cg-RX-API-DMAC7.html)
PT (1) PT2393830E (cg-RX-API-DMAC7.html)
SG (1) SG173523A1 (cg-RX-API-DMAC7.html)
SI (1) SI2393830T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010089554A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201105436B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1008802A2 (pt) * 2009-02-05 2016-03-08 Circassia Ltd composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição
CN118078979A (zh) 2011-04-29 2024-05-28 西莱克塔生物科技公司 用于降低针对治疗性蛋白的免疫应答的致耐受性合成纳米载体
US10434088B2 (en) 2013-05-03 2019-10-08 Selecta Biosciences, Inc. Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
WO2016037165A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
CA3055936A1 (en) 2017-03-11 2018-09-20 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108802216B (zh) * 2018-05-23 2021-04-16 山东出入境检验检疫局检验检疫技术中心 一种使用区域敏感性蛋白组和/或多肽组鉴别刺参产地的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340729C (en) 1988-03-23 1999-09-07 Mohan Bir Singh Ryegrass pollen allergen
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
CA2089735C (en) 1990-08-17 2008-03-18 Mohan Bir Singh Ryegrass pollen allergen
WO1992016554A1 (en) 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
ATE260342T1 (de) 1991-08-16 2004-03-15 Univ Melbourne Weidelgraspollen-allergen
WO1993010236A1 (en) 1991-11-15 1993-05-27 The University Of Melbourne Protein allergens of the species cynodon dactylon
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
JP3868480B2 (ja) 1992-08-14 2007-01-17 ザ・ユニバーシテイ・オブ・メルボルン ライグラス花粉アレルゲンのｔ細胞エピトープ
US6214358B1 (en) 1992-10-30 2001-04-10 Immulogic Pharamaceutical Corp. Protein allergens of the species Cynodon dactylon
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
NZ263913A (en) * 1993-03-12 1997-10-24 Immulogic Pharma Corp Lol pi protein allergen from ryegrass and related peptides coding sequences, vectors, protein production and use
NZ271818A (en) * 1993-08-13 1997-11-24 Immulogic Pharma Corp T cell epitopes of ryegrass pollen antigen
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
GB9412714D0 (en) 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
AU3338195A (en) * 1994-07-26 1996-02-22 University Of Manitoba Allergen peptides
US7112333B1 (en) * 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
AT402505B (de) 1995-08-02 1997-06-25 Biomay Prod & Handel Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.)
EP1044019A1 (en) 1998-01-09 2000-10-18 Circassia Limited Methods and compositions for desensitisation
DE19823097A1 (de) * 1998-05-22 1999-11-25 Max Planck Gesellschaft Mittel gegen saisonale Typ-I-Allergien und bakterielle Infektionen
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
DE60229979D1 (cg-RX-API-DMAC7.html) 2001-12-05 2009-01-02 Circassia Ltd
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
AU2003228133A1 (en) 2002-04-22 2003-11-03 Umc Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
DE102004035337A1 (de) * 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
EP1899367A4 (en) 2005-06-10 2009-06-24 Univ Singapore Mutant allergen(s)
DE202005009990U1 (de) * 2005-06-25 2006-11-02 Hengst Gmbh & Co.Kg Vorrichtung zum Abscheiden von Ölteilchen aus dem Kurbelgehäuseentlüftungsgas einer Brennkraftmaschine
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ES2425486T3 (es) 2007-05-09 2013-10-15 Circassia Limited Análisis de pronóstico para determinar la respuesta de células T a antígenos HLA y uso del mismo en el campo del trasplante de tejidos
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
WO2009022155A2 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptide with reduced dimer formation
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
BRPI1008802A2 (pt) * 2009-02-05 2016-03-08 Circassia Ltd composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição

Also Published As

Publication number Publication date
CN102307893B (zh) 2014-03-26
GB201001954D0 (en) 2010-03-24
JP2015180646A (ja) 2015-10-15
GB2469894B (en) 2011-09-07
US20120148612A1 (en) 2012-06-14
CA2751500A1 (en) 2010-08-12
PL2393830T3 (pl) 2015-07-31
BRPI1008802A2 (pt) 2016-03-08
GB2469894A (en) 2010-11-03
WO2010089554A8 (en) 2011-10-06
KR20110111307A (ko) 2011-10-10
US20140302071A1 (en) 2014-10-09
AU2010212193B2 (en) 2015-05-14
MX2011008179A (es) 2011-09-09
EP2393830A1 (en) 2011-12-14
HRP20150317T1 (hr) 2015-04-24
AU2010212193A1 (en) 2011-08-18
EP2393830B1 (en) 2015-01-28
CN103784952B (zh) 2016-08-17
IL214257A (en) 2016-06-30
JP5746053B2 (ja) 2015-07-08
ES2532759T3 (es) 2015-03-31
EA020792B1 (ru) 2015-01-30
NZ594268A (en) 2013-05-31
SG173523A1 (en) 2011-09-29
EP2393830B8 (en) 2015-03-18
WO2010089554A1 (en) 2010-08-12
CN103784952A (zh) 2014-05-14
EP2891662A1 (en) 2015-07-08
SI2393830T1 (sl) 2015-04-30
EA201171001A1 (ru) 2012-02-28
IL214257A0 (en) 2011-09-27
JP2012516693A (ja) 2012-07-26
JP6215252B2 (ja) 2017-10-18
HK1212358A1 (en) 2016-06-10
CN102307893A (zh) 2012-01-04
DK2393830T3 (en) 2015-04-27
US8753644B2 (en) 2014-06-17
ZA201105436B (en) 2012-09-26

Similar Documents

Publication Publication Date Title
IL217008A0 (en) Vaccine
GB0905570D0 (en) Combined vaccines
PL2496596T3 (pl) Peptydy terapeutyczne
GB201012651D0 (en) Peptides
GB201006165D0 (en) Vaccine
GB201001954D0 (en) Grass peptides for vaccine
GB201002559D0 (en) Birch peptides for vaccine
GB201014965D0 (en) Vaccine
GB0907935D0 (en) Vaccines
IL216102A0 (en) Combined measles-malaria vaccine
ZA201108446B (en) FViII-DERIVED PEPTIDES
GB201000522D0 (en) Vaccine
ZA201201387B (en) Bovine herpesvirus vaccine
GB201006324D0 (en) Vaccine
GB0918782D0 (en) A protein as an adjuvant for a vaccine
IL217194A0 (en) Vaccine
ZA201302154B (en) Vaccine
GB0901928D0 (en) Peptides for vaccine
GB0902344D0 (en) Peptides for vaccine
GB0917871D0 (en) Peptides for vaccine
GB0902345D0 (en) Peptides for vaccine
GB201001624D0 (en) Peptides for vaccine
GB201010058D0 (en) Peptide vaccine
GB201010056D0 (en) Polypeptide vaccine
GB0914545D0 (en) Vaccine